ExploreWatchlistsPricing
  1. JP-listed companies
  2. OLYMPUS CORPORATION
  3. Financials
  4. Cost of revenue

OLYMPUS CORPORATION (7733)

Market cap
¥2.07T
P/E ratio
21.5x
Olympus manufactures medical endoscopes and therapeutic devices for hospitals and healthcare providers worldwide, specializing in gastrointestinal, surgical, and diagnostic equipment.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndCost of revenue (Million JPY)YoY (%)
Mar 31, 2026356,586+13.69%
Mar 31, 2025313,635+0.82%
Mar 31, 2024311,087+9.12%
Mar 31, 2023285,074-4.07%
Mar 31, 2022297,172+9.65%
Mar 31, 2021271,014-9.01%
Mar 31, 2020297,844+4.77%
Mar 31, 2019284,297+47.61%
Mar 31, 2018192,601-24.97%
Mar 31, 2017256,708-4.69%
Mar 31, 2016269,341-1.99%
Mar 31, 2015274,820

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat